Tirzepatide 30mg Pen

8 WEEK COURSE

Type:
Dual GLP-1 and GIP receptor agonist.

Mechanism:
Activates both GLP-1 and glucose-dependent insulinotropic polypeptide (GIP) receptors, enhancing appetite regulation and glucose metabolism.

Benefits:

Greater Weight Loss:
Studies show more substantial weight reduction compared to semaglutide.

Enhanced Blood Sugar Control:
More robust glucose regulation due to dual hormone receptor activation.

Improved Lipid Profile:
Reduces triglycerides, LDL cholesterol, and total cholesterol.

Versatility:
Effective for both weight loss and type 2 diabetes management.

Potential Synergy:
Combined GLP-1 and GIP effects provide unique metabolic benefits, such as improved fat metabolism.